Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00367666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Diagnostic Tools to Stage Breast Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Notable

    Primary and study completion dates: Mar 12, 2026 to Mar 12, 2027

    Study Statusv13

  2. Notable

    Primary and study completion dates: Mar 12, 2025 to Mar 12, 2026

    Study Statusv12

  3. Notable

    Primary and study completion dates: Mar 12, 2024 to Mar 12, 2025

    Study Statusv11

  4. Notable

    Primary and study completion dates: Mar 12, 2023 to Mar 12, 2024

    Study Statusv10

  5. Notable

    Primary and study completion dates: Mar 12, 2022 to Mar 12, 2023

    Study Statusv9

Show 7 earlier versions

  1. Notable

    Primary and study completion dates: Mar 12, 2021 to Mar 12, 2022

    Study Statusv8

  2. Notable

    Primary and study completion dates: Aug 1, 2020 to Mar 12, 2021

    Start date: Mar 2002 to Mar 1, 2002

    Study Status, Oversightv7

  3. Minor

    2 amendments

    2 re-verifications since 2018-09-18, no change to tracked fields

    v5-v6

  4. Minor

    Primary completion date: Aug 1, 2020

    Completion date: Jul 2007 to Aug 1, 2020; Study arms: 0 to 1

    Study Status, Sponsor/Collaborators, Study Design, Arms and Interventions, Eligibilityv4

  5. Minor

    Study Status

    Re-verified, no change to tracked fields

    v3

  6. Minor

    Trial status: Recruiting to Active, Not Recruiting

    Site details revised

    Study Status, Study Design, Contacts/Locationsv2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.
Trial Details
NCT Number NCT00367666
Lead Sponsor University of Pennsylvania
Conditions Breast Cancer
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov